Suppr超能文献

组蛋白H2A和H4的N端尾巴由MEP50 WD重复蛋白定位,以便由PRMT5精氨酸甲基转移酶进行高效甲基化。

Histone H2A and H4 N-terminal tails are positioned by the MEP50 WD repeat protein for efficient methylation by the PRMT5 arginine methyltransferase.

作者信息

Burgos Emmanuel S, Wilczek Carola, Onikubo Takashi, Bonanno Jeffrey B, Jansong Janina, Reimer Ulf, Shechter David

机构信息

From the Department of Biochemistry, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York 10461 and.

JPT Peptide Technologies GmbH, Volmerstrasse 5, 12489 Berlin, Germany.

出版信息

J Biol Chem. 2015 Apr 10;290(15):9674-89. doi: 10.1074/jbc.M115.636894. Epub 2015 Feb 24.

Abstract

The protein arginine methyltransferase PRMT5 is complexed with the WD repeat protein MEP50 (also known as Wdr77 or androgen coactivator p44) in vertebrates in a tetramer of heterodimers. MEP50 is hypothesized to be required for protein substrate recruitment to the catalytic domain of PRMT5. Here we demonstrate that the cross-dimer MEP50 is paired with its cognate PRMT5 molecule to promote histone methylation. We employed qualitative methylation assays and a novel ultrasensitive continuous assay to measure enzyme kinetics. We demonstrate that neither full-length human PRMT5 nor the Xenopus laevis PRMT5 catalytic domain has appreciable protein methyltransferase activity. We show that histones H4 and H3 bind PRMT5-MEP50 more efficiently compared with histone H2A(1-20) and H4(1-20) peptides. Histone binding is mediated through histone fold interactions as determined by competition experiments and by high density histone peptide array interaction studies. Nucleosomes are not a substrate for PRMT5-MEP50, consistent with the primary mode of interaction via the histone fold of H3-H4, obscured by DNA in the nucleosome. Mutation of a conserved arginine (Arg-42) on the MEP50 insertion loop impaired the PRMT5-MEP50 enzymatic efficiency by increasing its histone substrate Km, comparable with that of Caenorhabditis elegans PRMT5. We show that PRMT5-MEP50 prefers unmethylated substrates, consistent with a distributive model for dimethylation and suggesting discrete biological roles for mono- and dimethylarginine-modified proteins. We propose a model in which MEP50 and PRMT5 simultaneously engage the protein substrate, orienting its targeted arginine to the catalytic site.

摘要

在脊椎动物中,蛋白质精氨酸甲基转移酶PRMT5与WD重复蛋白MEP50(也称为Wdr77或雄激素共激活因子p44)以异二聚体四聚体的形式复合。据推测,MEP50是将蛋白质底物募集到PRMT5催化结构域所必需的。在此,我们证明交叉二聚体MEP50与其同源PRMT5分子配对以促进组蛋白甲基化。我们采用定性甲基化测定法和一种新型超灵敏连续测定法来测量酶动力学。我们证明全长人PRMT5和非洲爪蟾PRMT5催化结构域均没有明显的蛋白质甲基转移酶活性。我们表明,与组蛋白H2A(1 - 20)和H4(1 - 20)肽相比,组蛋白H4和H3与PRMT5 - MEP50的结合更有效。通过竞争实验和高密度组蛋白肽阵列相互作用研究确定,组蛋白结合是通过组蛋白折叠相互作用介导的。核小体不是PRMT5 - MEP50的底物,这与通过H3 - H4组蛋白折叠的主要相互作用模式一致,该模式在核小体中被DNA掩盖。MEP50插入环上保守精氨酸(Arg - 42)的突变通过增加其组蛋白底物Km来损害PRMT5 - MEP50的酶促效率,这与秀丽隐杆线虫PRMT5相当。我们表明PRMT5 - MEP50更喜欢未甲基化的底物,这与二甲基化的分布模型一致,并暗示单甲基化和二甲基化精氨酸修饰的蛋白质具有不同的生物学作用。我们提出了一个模型,其中MEP50和PRMT5同时与蛋白质底物结合,将其靶向精氨酸定位到催化位点。

相似文献

2
Structure of the arginine methyltransferase PRMT5-MEP50 reveals a mechanism for substrate specificity.
PLoS One. 2013;8(2):e57008. doi: 10.1371/journal.pone.0057008. Epub 2013 Feb 25.
3
Protein arginine methyltransferase 5 catalyzes substrate dimethylation in a distributive fashion.
Biochemistry. 2014 Dec 23;53(50):7884-92. doi: 10.1021/bi501279g. Epub 2014 Dec 8.
6
The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond.
Cell Mol Life Sci. 2015 Jun;72(11):2041-59. doi: 10.1007/s00018-015-1847-9. Epub 2015 Feb 7.
9
Crystal structure of the human PRMT5:MEP50 complex.
Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):17960-5. doi: 10.1073/pnas.1209814109. Epub 2012 Oct 15.
10
Association of Polycomb group SUZ12 with WD-repeat protein MEP50 that binds to histone H2A selectively in vitro.
Biochem Biophys Res Commun. 2006 Jul 7;345(3):1051-8. doi: 10.1016/j.bbrc.2006.05.014. Epub 2006 May 11.

引用本文的文献

1
PRMT5 activity sustains histone production to maintain genome integrity.
bioRxiv. 2025 Jul 7:2025.07.03.663002. doi: 10.1101/2025.07.03.663002.
3
Discovery and Mechanism of 16-19F, a Novel Synthetic Lethal Inhibitor of the PRMT5•MTA Complex in MTAP-Deleted Cancer Cells.
ACS Chem Biol. 2025 Jun 20;20(6):1333-1346. doi: 10.1021/acschembio.5c00160. Epub 2025 May 29.
5
PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands.
J Exp Clin Cancer Res. 2025 Jan 11;44(1):11. doi: 10.1186/s13046-024-03270-x.
6
PRMT5/WDR77 Enhances the Proliferation of Squamous Cell Carcinoma via the ΔNp63α-p21 Axis.
Cancers (Basel). 2024 Nov 11;16(22):3789. doi: 10.3390/cancers16223789.
7
TBL2 Promotes Tumorigenesis via PRMT5/WDR77-Mediated AKT Activation in Breast Cancer.
Adv Sci (Weinh). 2024 Dec;11(47):e2400160. doi: 10.1002/advs.202400160. Epub 2024 Nov 5.
8
PRMT5 as a Potential Therapeutic Target in MYC-Amplified Medulloblastoma.
Cancers (Basel). 2023 Dec 15;15(24):5855. doi: 10.3390/cancers15245855.
9
PRMT5 and CDK4/6 inhibition result in distinctive patterns of alternative splicing in melanoma.
PLoS One. 2023 Nov 2;18(11):e0292278. doi: 10.1371/journal.pone.0292278. eCollection 2023.
10
In vitro methylation of the U7 snRNP subunits Lsm11 and SmE by the PRMT5/MEP50/pICln methylosome.
RNA. 2023 Nov;29(11):1673-1690. doi: 10.1261/rna.079709.123. Epub 2023 Aug 10.

本文引用的文献

1
Protein arginine methyltransferase 5 catalyzes substrate dimethylation in a distributive fashion.
Biochemistry. 2014 Dec 23;53(50):7884-92. doi: 10.1021/bi501279g. Epub 2014 Dec 8.
2
Phosphorylation and arginine methylation mark histone H2A prior to deposition during Xenopus laevis development.
Epigenetics Chromatin. 2014 Sep 6;7:22. doi: 10.1186/1756-8935-7-22. eCollection 2014.
3
A remodeled protein arginine methyltransferase 1 (PRMT1) generates symmetric dimethylarginine.
J Biol Chem. 2014 Mar 28;289(13):9320-7. doi: 10.1074/jbc.M113.535278. Epub 2014 Jan 29.
4
Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma.
Cancer Res. 2014 Mar 15;74(6):1752-65. doi: 10.1158/0008-5472.CAN-13-0884. Epub 2014 Jan 22.
6
Substrate specificity, processivity, and kinetic mechanism of protein arginine methyltransferase 5.
Biochemistry. 2013 Aug 13;52(32):5430-40. doi: 10.1021/bi4005123. Epub 2013 Aug 1.
7
Menin epigenetically represses Hedgehog signaling in MEN1 tumor syndrome.
Cancer Res. 2013 Apr 15;73(8):2650-8. doi: 10.1158/0008-5472.CAN-12-3158. Epub 2013 Apr 11.
8
Structure of the arginine methyltransferase PRMT5-MEP50 reveals a mechanism for substrate specificity.
PLoS One. 2013;8(2):e57008. doi: 10.1371/journal.pone.0057008. Epub 2013 Feb 25.
9
Overexpression of PRMT5 promotes tumor cell growth and is associated with poor disease prognosis in epithelial ovarian cancer.
J Histochem Cytochem. 2013 Mar;61(3):206-17. doi: 10.1369/0022155413475452. Epub 2013 Jan 4.
10
Crystal structure of the human PRMT5:MEP50 complex.
Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):17960-5. doi: 10.1073/pnas.1209814109. Epub 2012 Oct 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验